Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy
- PMID: 22821764
- PMCID: PMC3512228
- DOI: 10.1182/blood-2012-05-423236
Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy
Abstract
The results of recent clinical trials for the management of limited-stage Hodgkin lymphoma have led to considerable debate, especially regarding the role of radiation therapy. This review highlights those recent trials and provides perspectives regarding their interpretation from a radiation oncologist and a hematologist. The trial protocol is available at http://www.nejm.org/doi/suppl/10.1056/NEJMoa1111961/suppl_file/nejmoa1111961_protocol.pdf.
References
-
- Engert A, Plutschow A, Eich HT, et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med. 2010;363(7):640–652. - PubMed
-
- Hoppe RT, Advani RH, Ai WZ, et al. Hodgkin lymphoma. J Natl Compr Canc Netw. 2011;9(9):1020–1058. - PubMed
-
- Pusey WA. Cases of sarcoma and of Hodgkin's disease treated by exposure to X-rays: a preliminary report. JAMA. 1902;38:166–169.
-
- Gilbert R. Notre Methode De Roentgentherapie De La Lymphogranulomatose (Hodgkin): Resultats Eloignes. Acta Radiol. 1931:12.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
